ROYAL BANK OF CANADA - ZOSANO PHARMA CORP ownership

ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 1 filers reported holding ZOSANO PHARMA CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ZOSANO PHARMA CORP
ValueSharesWeighting
Q1 2022$01320.0%0.00%
Q4 2021$0132
-65.4%
0.00%
Q3 2021$0382
+189.4%
0.00%
Q2 2021$01320.0%0.00%
Q1 2021$0
-100.0%
132
-96.4%
0.00%
Q4 2020$2,000
-80.0%
3,632
-40.8%
0.00%
Q3 2020$10,0006,133
+1392.2%
0.00%
Q2 2020$0411
+1.7%
0.00%
Q1 2020$0
-100.0%
404
-94.9%
0.00%
Q4 2019$12,000
+1100.0%
7,900
+1655.6%
0.00%
Q3 2019$1,0004500.00%
Other shareholders
ZOSANO PHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 1,172,542$1,900,0001.90%
Aisling Capital Management LP 2,718,226$4,404,0001.41%
Telemetry Investments, L.L.C. 239,830$389,0000.84%
Sio Capital Management, LLC 452,542$733,0000.14%
AJ WEALTH STRATEGIES, LLC 136,476$221,0000.02%
CAAS CAPITAL MANAGEMENT LP 453,168$734,0000.02%
Highlander Capital Management, LLC 10,000$16,0000.01%
Qube Research & Technologies Ltd 427,894$693,0000.01%
Alyeska Investment Group, L.P. 295,953$479,0000.01%
WINTON GROUP Ltd 120,182$195,0000.01%
View complete list of ZOSANO PHARMA CORP shareholders